Chemomab Therapeutics Ltd. (CMMB)
NASDAQ: CMMB · Real-Time Price · USD
1.970
+0.090 (4.79%)
Mar 9, 2026, 2:50 PM EDT - Market open
Chemomab Therapeutics Market Cap
Chemomab Therapeutics has a market cap or net worth of $12.13 million as of March 9, 2026. Its market cap has decreased by -63.67% in one year.
Market Cap
12.13M
Enterprise Value
1.52M
1-Year Change
-63.67%
Ranking
Category
Stock Price
$1.97
Market Cap Chart
Since March 17, 2021, Chemomab Therapeutics's market cap has decreased from $631.18M to $12.13M, a decrease of -98.08%. That is a compound annual growth rate of -54.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 11.57M | 13.94% |
| Dec 31, 2025 | 10.16M | -70.24% |
| Dec 31, 2024 | 34.13M | 466.14% |
| Dec 29, 2023 | 6.03M | -83.65% |
| Dec 30, 2022 | 36.88M | -53.12% |
| Dec 31, 2021 | 78.67M | -87.54% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NewcelX | 12.63M |
| BioCardia | 12.52M |
| Phio Pharmaceuticals | 12.49M |
| BioAtla | 12.46M |
| CytoMed Therapeutics | 12.12M |
| Soligenix | 12.00M |
| Cellectar Biosciences | 11.70M |
| CalciMedica | 11.45M |